Christina Curtis, PhD, MSc is an Assistant Professor in the Departments of Medicine (Oncology) and Genetics at Stanford University School of Medicine where she leads the Cancer Systems Biology Group and serves as Co-Director of the Molecular Tumor Board at the Stanford Cancer Institute. Christina’s research leverages genome-scale data, coupled with computational modeling and iterative experimentation in order to define the molecular determinants and dynamics of tumor progression and to develop predictive and prognostic biomarkers. Through these studies, she has redefined the molecular map of breast cancer, resulting in the discovery of novel patient subgroups with distinct clinical outcomes. She and her team have also pioneered novel approaches infer signals of selection and patient-specific parameters from cancer genome sequencing data, leading to new paradigms in understanding clonal evolution. Christina was the recipient of the 2012 V Foundation for Cancer V Scholar Award, the 2012 STOP Cancer Research Career Development Award, a 2016 American Association for Cancer Research (AACR) Career Development Award and was named a National Academy of Science (NAS) Kavli Frontier of Science fellow in 2016. She is the principal investigator on grants from the NIH/NCI, Department of Defense, Breast Cancer Research Foundation, Susan G. Komen Foundation, V Foundation for Cancer Research and Emerson Collective Cancer Research Fund. Additionally, she serves on the Editorial Boards of Breast Cancer Research, Carcinogenesis: Integrative Biology, the Journal of Computational Biology and JCO Precision Oncology and is a member of the Scientific Advisory Committee for the Ontario Institute for Cancer Research (OICR) Adaptive Oncology Initiative and the Cancer Research UK (CRUK) Early Detection Research Committee.